20250228938. Th (Whitehead Institute for Biomedical Research)
THE COMBINATION OF MACROPHAGE-DIRECTED IMMUNOTHERAPY AND TARGETED AGENTS FOR TREATMENT OF CANCER
Abstract: the present disclosure provides methods and compositions related to the combination therapy of a macrophage-directed immunotherapy and a targeted agent. the combination of the macrophage-directed immunotherapy and a targeted agent is useful in treating and/or preventing cancer (e.g., lung cancer) in a subject.
Inventor(s): Kipp Weiskopf, Aaron Hata
CPC Classification: A61K39/39558 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250228938